Company profile: Magenta Therapeutics
1.1 - Company Overview
Company description
- Provider of biotechnology therapeutics that unlock the power of stem cell biology.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Magenta Therapeutics
Acousia Therapeutics
HQ: Germany
Website
- Description: Provider of small-molecule therapeutics for sensorineural hearing loss, with expertise in identifying and developing drug candidates to enhance and preserve natural hearing. Products include ACOU085, an etiology-agnostic otoprotective candidate preventing chemotherapy-induced hearing loss and sensory hair cell death, and ACOU082, an oral Kv7.4 activator to enhance natural hearing and protect against age-related loss.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acousia Therapeutics company profile →
Trail Bio
HQ: United States
Website
- Description: Provider of human iPSC-derived cells and optimization technologies for drug discovery and cell therapies. Offers the HD-DoE Technology Platform, applying high-dimensional design-of-experiments to optimize cell growth and differentiation, and TrailBio Cells. Portfolio includes TrailBio Pre-Myelinating Oligodendrocytes Kit, Vascular Leptomeningeal Cells, and Insulin-Producing Islet-Like Clusters for screening and disease modeling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trail Bio company profile →
Outpace Bio
HQ: United States
Website
- Description: Provider of innovative cell therapies designed to enhance cancer treatment efficacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Outpace Bio company profile →
Neurona Therapeutics
HQ: United States
Website
- Description: Provider of cell therapies for neurological disorders, including NRTX-1001, a one-time dose therapy for drug-resistant focal epilepsy using human MGE-type inhibitory GABAergic interneurons derived from pluripotent stem cells; myelinating glial cell therapy using human oligodendrocytes to restore myelin; and gene-edited neural cell therapies for targeted delivery to the CNS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neurona Therapeutics company profile →
Coapt Systems
HQ: United States
Website
- Description: Provider of bio-absorbable implants for soft tissue fixation during facial cosmetic surgery, engaged in the design, development, manufacture, and marketing of these devices. Offerings include the ENDOTINE Forehead 3.0 bioabsorbable brow fixation device and ENDOTINE Forehead Instrument Kits comprising insertion tools, drill bits, and sterilization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Coapt Systems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Magenta Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Magenta Therapeutics
2.2 - Growth funds investing in similar companies to Magenta Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Magenta Therapeutics
4.2 - Public trading comparable groups for Magenta Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →